AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get beauty and skincare favorites delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Kenvue reported a 5.1% increase in second-quarter sales for its Skin Health and Beauty division, with growth supported by skincare, hair care and e-commerce. The company also reported 3% higher group revenue and continued a $250 million restructuring program; its proposed acquisition by Kimberly-Clark remains subject to regulatory approvals.

Kenvue reported a 5.1% increase in second-quarter sales for its Skin Health and Beauty division, citing growth in skincare, hair care and e-commerce. The personal-care company also recorded 3% growth in group revenue and said it continued a $250 million restructuring program as it prepares for a proposed acquisition by Kimberly-Clark.

Across the company, revenue reached $3.96 billion, up 3% from the year-earlier period, according to the results summarized by Global Cosmetics News. Organic sales rose 1.6%, while net income was $456 million. These measures describe different aspects of performance: reported revenue reflects the total sales figure, while organic sales growth excludes certain effects such as currency movements and portfolio changes.

Within Skin Health and Beauty, the company reported 3.7% organic sales growth, supported by higher volumes and pricing, with gains across all regions. The source report gives the division’s sales increase as 5.1% and its organic growth as 3.7%; it does not provide a detailed reconciliation of the two figures. It attributes performance to brands including Neutrogena and OGX, as well as digital sales and new product introductions.

Kenvue said it continued work on a $250 million restructuring program intended to improve supply-chain efficiency and reduce operating costs. The company’s proposed acquisition by Kimberly-Clark remains on track for completion in the fourth quarter of 2026, subject to regulatory approvals, according to the source report. The announcement does not establish that the transaction has received all required approvals or that it is complete.

At a glance
reportWhen: Second-quarter results; proposed acquis…
The developmentKenvue reported second-quarter growth in Skin Health and Beauty alongside higher group revenue and continued restructuring.

Skin Care Supports Kenvue’s Sales

The divisional result shows that Skin Health and Beauty contributed to Kenvue’s growth during the quarter, even as organic sales across the group increased by a more modest 1.6%. Gains in skincare and hair care, alongside higher digital sales, point to the importance of those products and channels in the company’s current results.

The figures also give investors and employees a view of Kenvue’s business while it is pursuing two changes: a cost-focused restructuring and a proposed combination with Kimberly-Clark. The reported growth is a measure of recent sales performance, not evidence that restructuring savings have already been achieved or that the acquisition will close. Regulatory approval and execution remain important conditions for the planned transaction.

For consumers, the report identifies brands and product categories contributing to sales, but it does not announce a specific product launch, price change or alteration to availability. Its immediate significance is chiefly financial and corporate: Kenvue reported growth in a key division while continuing efforts to change its cost base and ownership structure.

Products Worth Considering

Therabody Theragun Mini 3rd Gen Massage Gun (Travel Essential, Black)

Therabody Theragun Mini 3rd Gen Massage Gun (Travel Essential, Black)

As an affiliate, we earn on qualifying purchases.

Results Ahead of a Proposed Deal

Kenvue is a consumer health and personal-care company whose portfolio includes skincare and hair-care brands such as Neutrogena and OGX. Its Skin Health and Beauty division is one part of a broader business, so the division’s sales rate should not be treated as the growth rate for the entire company. In this quarter, the reported divisional increase of 5.1% and organic growth of 3.7% are separate figures; the source does not explain their full calculation or reconciliation.

The results arrive while Kenvue is carrying out a $250 million restructuring program and pursuing a proposed acquisition by Kimberly-Clark. The source says the deal remained on track for a fourth-quarter 2026 close, conditional on regulatory approvals. That is a stated timetable, not a guarantee of completion. The reported quarter provides a snapshot of business performance before any completed combination.

“The Skin Health and Beauty division delivered 3.7 percent organic sales growth, supported by higher volumes and pricing, with gains recorded across all regions.”

— Global Cosmetics News, summarizing Kenvue’s results

Deal Timing and Growth Drivers

The available report does not give a detailed breakdown of sales by region, product category or e-commerce, nor does it quantify the separate contributions from pricing, volume, new products and digital sales. It also does not explain the difference between the division’s 5.1% sales increase and 3.7% organic growth, so those measures should not be treated as interchangeable.

Further details about the restructuring’s savings, timing and effect on profitability are not included in the source material. The proposed Kimberly-Clark acquisition remains subject to regulatory approvals, and the report does not identify the remaining review steps, provide a final closing date or confirm that the transaction will be completed as planned.

Regulatory Review and Cost Plan

Kenvue’s next milestones are continued implementation of its restructuring program and progress through the regulatory process for the proposed Kimberly-Clark acquisition. The company’s stated target is to complete the deal in the fourth quarter of 2026, subject to approvals. That timetable may change if regulatory review or other required steps take longer than expected.

Subsequent company updates and filings can clarify whether approvals have been secured, whether the proposed closing schedule still holds, and how restructuring costs and savings are developing. Future results will also show whether the reported gains in Skin Health and Beauty and digital sales continue; the current report alone does not establish a longer-term trend.

Key Questions

What did Kenvue report for Skin Health and Beauty?

Kenvue reported a 5.1% increase in second-quarter sales for the division and 3.7% organic sales growth, with the source citing higher volume and pricing and gains across all regions.

How did Kenvue perform overall?

Group revenue rose 3% to $3.96 billion, organic sales increased 1.6%, and net income was $456 million, according to the source report.

What contributed to division growth?

The report points to skincare, hair care and e-commerce, naming Neutrogena and OGX and citing digital sales and new product introductions. It does not quantify each factor’s contribution.

When is the Kimberly-Clark acquisition expected to close?

Kenvue’s proposed acquisition by Kimberly-Clark is reported as on track for the fourth quarter of 2026, subject to regulatory approvals. The source does not confirm that approvals have been completed.

What is Kenvue’s restructuring program intended to do?

The $250 million program is intended to improve supply-chain efficiency and reduce operating costs. The source does not provide a timetable for savings or quantify the program’s impact on profitability.

Source: globalcosmeticsnews.com

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

We Went Bigger Than Ever For This Year’s Best Of Beauty Box

This year’s Best of Beauty Box expanded significantly, reflecting increased consumer interest in beauty products. Details are confirmed, but reasons for growth remain unconfirmed.

Tinted Sunscreens vs. BB Creams: Differences and Uses

Gaining clarity on tinted sunscreens versus BB creams helps you choose the perfect product—discover which one suits your skincare needs best.

Kao USA issues recall notice for Oribe Serene Scalp Densifying Shampoo

Kao USA has issued a recall for Oribe Serene Scalp Densifying Shampoo due to contamination concerns involving Pluralibacter gergoviae. No injuries reported yet.

Bath & Body Works Expands Into Sensitive Skin With New Essentials Franchise

Bath & Body Works has launched Essentials, a sensitive-skin body care range in the U.S. and Canada, with selected products also on Amazon.